ALLMedicine™ Geriatric Psychiatry Center

Mar 9th, 2022 - This study explored factors influencing a physician's choice to pursue geriatric psychiatry fellowship training from fellow and program director perspectives to improve recruitment into this critical need specialty. Questionnaires were sent to the...

Nov 7th, 2021 - To assess perspectives on pharmacogenetic (PGx) testing among members of the American Association of Geriatric Psychiatry (AAGP). Cross-sectional survey. Members of the AAGP. Anonymous web-based survey consisting of 41 items covering experiences, ...

Aug 24th, 2020 - The American Association for Geriatric Psychiatry (AAGP) Scholars Program was developed to recruit trainees into geriatric psychiatry fellowships and is considered a pipeline for fellowship recruitment. Nonetheless, the number of trainees entering...

Jul 7th, 2020 - One effect of the COVID-19 pandemic is the disruption of in-person clinical experiences within geriatric psychiatry residency education. Online resources for trainees are needed to fill resultant gaps. The American Association of Geriatric Psychia...

Apr 10th, 2020 - The number of physicians trained in geriatric psychiatry is dwindling. The American Association for Geriatric Psychiatry (AAGP) developed novel educational programs designed to foster interest in the field. The objective of this study was to compa...

Apr 6th, 2022 - Atypical anxiety in adults with Parkinson's disease ranged from 15% to 51% in a systematic review of 60 studies. Dr Nadeeka Dissanayaka Anxiety is common in Parkinson's disease (PD) and has been shown to increase functional disability and decrease...

Apr 3rd, 2018 - HONOLULU, Hawaii — Valbenazine (Ingrezza, Neurocrine Biosciences) is safe and effective over the long term as a treatment for tardive dyskinesia (TD) in older patients, new research suggests. Dr Martha Sajatovic Further results from the KINECT 3 a...

Mar 19th, 2018 - HONOLULU, Hawaii — The atypical antipsychotic brexpiprazole (Rexulti, Otsuka and Lundbeck) is safe and effective for treating agitation in patients with dementia related to Alzheimer's disease (AD) — at least at its highest dose, new research sugg...

Mar 19th, 2018 - HONOLULU, Hawaii — The atypical antipsychotic brexpiprazole (Rexulti, Otsuka and Lundbeck) is safe and effective for treating agitation in patients with dementia related to Alzheimer's disease (AD) — at least at its highest dose, new research sugg...

Mar 19th, 2018 - HONOLULU, Hawaii — Ageism is not only prevalent in society, it's also widespread in medical education and in the clinic. This situation, say leading experts, results in substandard care and poor outcomes for older patients. A symposium here at the...